Ipratropium is a bronchodilator medication that works to dilate the airways of the lungs. The FDA-approved indications are bronchospasms associated with chronic obstructive lung disease (COPD), including emphysema and chronic bronchitis.Â Non-FDA indications include asthma exacerbations and clearance of secretions, especially in intubated patients in the ICU.